Related Experiment Video
Updated: Feb 7, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Interaction between white coat effect and hypertension on arterial stiffness
Lin Jin1, Zhenyi Li1, Xinyi Li2,3
1Department of Ultrasound, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine.
The white coat effect (WCE) is linked to increased arterial stiffness and higher cardiovascular disease (CVD) risk in hypertensive individuals. This study found WCE independently predicts greater arterial stiffness, particularly in women.
Area of Science:
- Cardiology
- Hypertension Research
- Vascular Biology
Background:
- The white coat effect (WCE), characterized by elevated blood pressure in clinical settings, is a debated cardiovascular disease (CVD) risk factor.
- Existing research on the association between WCE, hypertension, and arterial stiffness remains inconsistent, necessitating further investigation.
Purpose of the Study:
- To investigate the interaction between WCE and hypertension concerning arterial stiffness.
- To determine if WCE is an independent predictor of arterial stiffness and CVD risk.
Main Methods:
- A cohort of 7584 participants, including controls and hypertensive individuals, was categorized into four groups: control, white coat hypertension (WCH), hypertension, and white coat uncontrolled hypertension (WUCH).
- Arterial stiffness was assessed using arterial velocity pulse index (AVI) and arterial pressure volume index (API) via cuff oscillometry.
- Logistic regression and restrictive cubic spline (RCS) analyses were employed to evaluate risk factors and the API-pulse pressure relationship.
Main Results:
- Participants with WUCH were older and exhibited higher pulse pressure (PP) and API compared to those with WCH.
- Both WCH/WUCH and API were identified as independent determinants of arterial stiffness and significant predictors of high CVD risk in multivariable analyses.
- A significant J-shaped relationship was observed between API and PP in both WCE and non-WCE individuals.
Conclusions:
- Individuals experiencing the white coat effect demonstrate increased peripheral arterial stiffness, with a more pronounced effect noted in women.
- The study confirms WCE as an independent risk factor associated with elevated CVD risk.
- A J-shaped association between arterial stiffness indices (API) and pulse pressure (PP) exists irrespective of WCE status.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension I: Introduction

